These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27793885)

  • 21. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells.
    Zhao G; Han X; Zheng S; Li Z; Sha Y; Ni J; Sun Z; Qiao S; Song Z
    Oncol Rep; 2016 Feb; 35(2):1065-74. PubMed ID: 26573768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms underlying chemopreventive potential of curcumin: Current challenges and future perspectives.
    Kumar G; Mittal S; Sak K; Tuli HS
    Life Sci; 2016 Mar; 148():313-28. PubMed ID: 26876915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin inhibits the proliferation and invasiveness of MHCC97-H cells via p38 signaling pathway.
    Zhang K; Rui X; Yan X
    Drug Dev Res; 2014 Nov; 75(7):463-8. PubMed ID: 25195681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells.
    Mackenzie GG; Queisser N; Wolfson ML; Fraga CG; Adamo AM; Oteiza PI
    Int J Cancer; 2008 Jul; 123(1):56-65. PubMed ID: 18386790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Turmeric - not only spice].
    Zdrojewicz Z; Szyca M; Popowicz E; Michalik T; Śmieszniak B
    Pol Merkur Lekarski; 2017 Jun; 42(252):227-230. PubMed ID: 28662006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
    Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
    Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential anticancer properties and mechanisms of action of curcumin.
    Vallianou NG; Evangelopoulos A; Schizas N; Kazazis C
    Anticancer Res; 2015 Feb; 35(2):645-51. PubMed ID: 25667441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
    Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function.
    Osterman CJ; Lynch JC; Leaf P; Gonda A; Ferguson Bennit HR; Griffiths D; Wall NR
    PLoS One; 2015; 10(7):e0132845. PubMed ID: 26177391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin protects against hyperosmoticity-induced IL-1beta elevation in human corneal epithelial cell via MAPK pathways.
    Chen M; Hu DN; Pan Z; Lu CW; Xue CY; Aass I
    Exp Eye Res; 2010 Mar; 90(3):437-43. PubMed ID: 20026325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic Effects of Curcumin against Bladder Cancer: A Review of Possible Molecular Pathways.
    Ashrafizadeh M; Yaribeygi H; Sahebkar A
    Anticancer Agents Med Chem; 2020; 20(6):667-677. PubMed ID: 32013836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms of curcumins suppressing effects on tumorigenesis, angiogenesis and metastasis, focusing on NF-κB pathway.
    Panahi Y; Darvishi B; Ghanei M; Jowzi N; Beiraghdar F; Varnamkhasti BS
    Cytokine Growth Factor Rev; 2016 Apr; 28():21-9. PubMed ID: 26774676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
    Jurenka JS
    Altern Med Rev; 2009 Jun; 14(2):141-53. PubMed ID: 19594223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest.
    Wang YT; Liu HS; Su CL
    Int J Food Sci Nutr; 2014 May; 65(3):368-74. PubMed ID: 24438326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple biological activities of curcumin: a short review.
    Maheshwari RK; Singh AK; Gaddipati J; Srimal RC
    Life Sci; 2006 Mar; 78(18):2081-7. PubMed ID: 16413584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity.
    Biswas SK; McClure D; Jimenez LA; Megson IL; Rahman I
    Antioxid Redox Signal; 2005; 7(1-2):32-41. PubMed ID: 15650394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin inhibits liver cancer by inhibiting DAMP molecule HSP70 and TLR4 signaling.
    Ren B; Luo S; Tian X; Jiang Z; Zou G; Xu F; Yin T; Huang Y; Liu J
    Oncol Rep; 2018 Aug; 40(2):895-901. PubMed ID: 29901164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel curcumin analog inhibits canonical and non-canonical functions of telomerase through STAT3 and NF-κB inactivation in colorectal cancer cells.
    Chung SS; Dutta P; Chard N; Wu Y; Chen QH; Chen G; Vadgama J
    Oncotarget; 2019 Jul; 10(44):4516-4531. PubMed ID: 31360301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin and cancer: an "old-age" disease with an "age-old" solution.
    Anand P; Sundaram C; Jhurani S; Kunnumakkara AB; Aggarwal BB
    Cancer Lett; 2008 Aug; 267(1):133-64. PubMed ID: 18462866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular and cellular mechanisms of curcumin action--beneficial effect on organism].
    Sikora-Polaczek M; Bielak-Zmijewska A; Sikora E
    Postepy Biochem; 2011; 57(1):74-84. PubMed ID: 21735822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.